Showing results (961-970 of 1,505) with videos related to
Sort By:
Pageof 151
Journal of Neuroinflammation|May 15, 2022
Epigenetic regulation of innate immune memory in microgliaXiaoming Zhang, Laura Kracht, Antonio M Lerario, et al.British Journal of Cancer|July 9, 2024
Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands: time trends and the association with tumour gradeRebecca L O'Leary, Lucien E M Duijm, Liesbeth J Boersma, et al.Journal of Cachexia, Sarcopenia and Muscle|September 20, 2019
Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinomaAnna C H Willemsen, Ann Hoeben, Roy I Lalisang, et al.Breast Cancer Research and Treatment|April 23, 2017
MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapyMette S van Ramshorst, Claudette E Loo, Emilie J Groen, et al.Acta Neuropathologica|January 26, 2005
Expression pattern of apoptosis-related markers in Huntington's diseaseJosé C Vis, Ellis Schipper, Roelie T de Boer-van Huizen, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 28, 2025
Basic Science and PathogenesisLaura E M Wisse, Maud M A Bouwman, Alex J Wesseling, et al.Investigative Radiology|February 11, 2016
Prediction Model For Extensive Ductal Carcinoma In Situ Around Early-Stage Invasive Breast CancerFloortje M Knuttel, Bas H M van der Velden, Claudette E Loo, et al.Breast Cancer Research and Treatment|January 26, 2019
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIESZsolt Szijgyarto, Koen D Flach, Mark Opdam, et al.The European Respiratory Journal|April 14, 2006
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological functionA Zandvoort, Y M van der Geld, M R Jonker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2016
BRCA1-Mutated Estrogen Receptor-Positive Breast Cancer Shows BRCAness, Suggesting Sensitivity to Drugs Targeting Homologous Recombination DeficiencyEsther H Lips, Rashmie D Debipersad, Caroline E Scheerman, et al.Pageof 151